UTICA, N.Y. — ConMed Corp. (NASDAQ: CNMD) has appointed Peter Shagory as the company’s executive vice president of strategy and corporate development. He will manage the Utica–based surgical-device maker’s global business development and strategic business opportunities.
Shagory brings more than 20 years of experience in health-care venture investing and mergers and acquisitions through his previous venture capital, investment banking, and corporate roles, according to a ConMed news release.
Most recently, he led the strategy and business-development efforts for Cardinal Health’s Medical Products Group, where he played a key role in Cardinal Health’s entry into the interventional cardiovascular and the advanced wound-care categories. Prior to that, Shagory led the health-care and life sciences investment effort at Baird Venture Partners, focusing on medical technology and research tools and diagnostics.
(Sponsored)
CECL Accounting Standard: What You Need to Know
The Financial Accounting Standards Board Accounting Standards Codification (FASB ASC) 326, Financial Instruments-Credit Losses, became effective for all entities on January 1, 2023. This accounting standard introduces the current expected
How To Seamlessly & Responsibly Integrate AI Into the Workplace
Artificial intelligence (AI) is one of the hottest topics in today’s tech and office technology thought leadership. Everyone seems to be aware of the capabilities of AI, but some might
“[Shagory’s] deep understanding of business development strategies and his investment expertise will be invaluable …,” Curt R. Hartman, ConMed’s president and CEO, said in the release.
Shagory earned an MBA from Dartmouth College’s Tuck School of Business and a bachelor’s degree in finance from Miami University of Ohio.
Contact The Business Journal News Network at news@cnybj.com
